AzTrials
AzTrials

Nutrition, HealthyNCT05917223

The Impact of Plant-based Blends on Skeletal Muscle Protein Synthesis Rates in Older Adults

A study testing Milk protein ingestion, Cron protein ingestion and Corn+Pea protein ingestion in people with Nutrition, Healthy, run by McMaster University at 1 site in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Lifestyle interventions such as physical activity and dietary habits are the most effective non-pharmacological strategies to combat the loss of muscle mass and the development of mobility limitations with aging. Read more about this study

Who is it for?
Ages 60 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Nutrition, Healthy
What is being tested?
Milk protein ingestion, Cron protein ingestion and Corn+Pea protein ingestion
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
48 participants
Where
1 siteCanada
Study dates
1 Jul 2023to 31 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Older (60-80 y) men and women
  • Be in good general health
  • Non-smoking
  • Recreationally active but not meet Canada's Physical Activity Guidelines (150 min of moderate-intensity exercise/week)
  • Have a body mass index (BMI) between 18.5-30 kg/m2 (inclusive)
  • Willing and able to provide informed consent (speaks and understands English)

Who cannot join

  • Use of tobacco or related products
  • Use assistive walking devices (e.g., cane or walker)
  • Any concurrent medical, orthopedic, or psychiatric condition that, in the opinion of the investigator, would compromise his/her ability to comply with the study requirements
  • History of cancer within the last 5 years, except basal cell carcinoma, non-squamous skin carcinoma, prostate cancer or carcinoma in situ with no significant progression over the past 2 years
  • Significant orthopedic, cardiovascular, pulmonary, renal, liver, infectious disease, immune disorder, metabolic/endocrine, neuromuscular or bone wasting disorders
  • Any cachexia-related condition (e.g., relating to cancer, tuberculosis or human immunodeficiency virus infection and acquired immune deficiency syndrome) or any genetic muscle diseases or disorders
Show all 12Show fewer
  • History of statin myalgia
  • Current illnesses which could interfere with the study (e.g., prolonged severe diarrhea, regurgitation, difficulty swallowing)
  • Excessive alcohol consumption (>21 units/week)
  • History of bleeding diathesis, platelet or coagulation disorders, or antiplatelet/anticoagulation therapy (up to 81mg of baby aspirin per day taken as a prophylactic is permitted).
  • Routine/daily usage of non-steroidal anti-inflammatory drugs (NSAIDS, prescription use or daily use of over-the-counter medication), use of corticosteroids, testosterone replacement therapy (ingestion, injection, or transdermal), any anabolic steroid, creatine, whey protein supplements, casein or branched-chain amino acids (BCAAs) within 45 days prior to screening.
  • A history of falls determined by a score >25 on the Falls Efficacy Scale-International (FES-I).

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Ivor Wynne Centre

    Hamilton, Ontario, L8S 4L8

Other trials in Canada

About this study

Official title: The Impact of Plant-based Protein Blends, With or Without Resistance Exercise, on Skeletal Muscle Protein Synthesis Rates in Older Men and Women

Lifestyle interventions such as physical activity and dietary habits are the most effective non-pharmacological strategies to combat the loss of muscle mass and the development of mobility limitations with aging. Resistance training (i.e., strengthening exercise) provides a strong stimulus to build muscle mass, and protein provides the essential building blocks. Therefore, an individual's dietary practices can influence the effectiveness of an exercise program - when combined, they work together to increase the muscle-building response. However, not all proteins are equally effective at bringing about muscle growth.

Therefore, the purpose of this study is to investigate the effect of a higher-quality plant-based protein blend with lifting weight on muscle building in older men and women.

Read the detailed description

Dietary interventions are similarly pertinent in preventing skeletal muscle mass losses with aging. Dietary protein ingestion provides the necessary substrates (i.e., amino acids) essential for skeletal muscle development, health, and, thus, maintenance of muscle mass. Protein ingestion and resistance exercise training (RET) increase muscle protein synthesis (MPS), but when combined, they act synergistically to maximize MPS. Importantly, not all protein sources are equivalent in their ability to support increased rates of MPS. A recent study confirmed that a blend of plant proteins at a large dose of 30 g resulted in similar MPS as 30g of milk protein in young men. However, the impact of a unique plant-derived protein blend on MPS in older individuals is yet to be determined. Therefore, the purpose of this study is to address that knowledge gap by assessing the skeletal muscle anabolic potential of a plant-based protein blend (i.e., corn and pea) on rates of MPS, with or without additive exercise in older men and women.

Being tested
Milk protein ingestion, Cron protein ingestion, Corn+Pea protein ingestion, Non-protein, low energy
Keywords
Plant-based protein, Protein quality

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Milk protein ingestionDietary supplement

    It's just an acute intervention, so the participant assigned to the Milk protein ingestion group will consume 20 g of milk protein during infusion protocol.

  • Cron protein ingestionDietary supplement

    It's just an acute intervention, so the participant assigned to the Corn protein ingestion group will consume 20 g of corn protein isolation during infusion protocol.

  • Corn+Pea protein ingestionDietary supplement

    It's just an acute intervention, so the participant assigned to the Corn+Pea protein ingestion group will consume 20 g of Corn+Pea protein isolation during infusion protocol.

  • Non-protein, low energyDietary supplement

    It's just an acute intervention, so the participant assigned to the Non-protein, low energy group will consume 20 g of carbohydrate during infusion protocol.

Study groups in NCT05917223
Study groupRoleWhat they receive
Milk protein ingestionExperimentalConsuming 20 g of Milk Protein dissolved in 350mL of water, one time at the experiment visit
Receives: Dietary Supplement: Milk protein ingestion
Corn protein ingestionExperimentalConsuming 20 g of Corn protein isolation dissolved in 350mL of water, one time at the experimental visit
Receives: Dietary Supplement: Cron protein ingestion
Corn+Pea protein ingestionExperimentalConsuming 20 g of Corn+Pea protein isolation dissolved in 350mL of water, one time at the experimental visit
Receives: Dietary Supplement: Corn+Pea protein ingestion
Non-protein, low energyExperimentalConsuming 20 g of carbohydrate dissolved in 350mL of water, one time at the experimental visit
Receives: Dietary Supplement: Non-protein, low energy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Muscle protein synthesis rate

    The rate of amino acids incorporation into skeletal muscle protein

    Measured: Over 5 hours after intervention

Secondary outcomes (4)
  1. Plasma amino acid concentration

    Amino acid content in plasma after ingestion of the supplements

    Measured: Over 5 hours after intervention

  2. Muscle anabolic protein signaling

    Protein signaling changes in skeletal muscle tissue

    Measured: At pre and 5 hours after intervention

  3. Plasma glucose

    Glucose content in plasma

    Measured: Over 5 hours after intervention

  4. Plasma insulin

    Insulin content in plasma

    Measured: Over 5 hours after intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jun 2023
  2. Study start1 Jul 2023
  3. Primary completion30 Jun 2024
  4. Study completion31 May 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
This study is double-blind, placebo-controlled, randomized parallel control trial
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
48 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05917223
Sponsor's protocol ID
16408
Status last verified
Oct 2024
First submitted
11 Jun 2023
Last updated
3 Oct 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Lim C, Lees MJ, Janssen TAH, McKendry J, Smith C, Ho M, Sutoski A, Wu Y, Greaves E, da Costa FP, Varanan M, Goessens JPB, Senden JM, Loon LJCV, Phillips SM. Corn protein alone, or in blends, stimulates muscle protein synthesis comparable to milk protein, with or without resistance exercise, in older adults. J Nutr. 2026 Oct 26:101895. doi: 10.1016/j.tjnut.2026.101895. Online ahead of print.

    PubMed 42933646

Questions about this trial

What is this clinical trial studying?

A study testing Milk protein ingestion, Cron protein ingestion and Corn+Pea protein ingestion in people with Nutrition, Healthy, run by McMaster University at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 3 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Muscle protein synthesis rate (time frame: Over 5 hours after intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05917223, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in